The epidemiology and control of Acinetobacter baumannii in health care facilities
- PMID: 16447117
- DOI: 10.1086/500202
The epidemiology and control of Acinetobacter baumannii in health care facilities
Abstract
Acinetobacter baumannii is a ubiquitous pathogen capable of causing both community and health care-associated infections (HAIs), although HAIs are the most common form. This organism has emerged recently as a major cause of HAI because of the extent of its antimicrobial resistance and its propensity to cause large, often multifacility, nosocomial outbreaks. The occurrence of outbreak is facilitated by both tolerance to desiccation and multidrug resistance, contributing to the maintenance of these organisms in the hospital environment. In addition, the epidemiology of A. baumannii infection is often complex, with the coexistence of epidemic and endemic infections, the latter of which often is favored by the selection pressure of antimicrobials. The only good news is that potentially severe A. baumannii infection, such as bacteremia or pneumonia in patients in the intensive care unit who are undergoing intubation, do not seem to be associated with a higher attributable mortality rate or an increased length of hospital stay.
Comment in
-
Acinetobacter infection: what was the true impact during the Vietnam conflict?Clin Infect Dis. 2006 Aug 1;43(3):383-4. doi: 10.1086/505601. Epub 2006 Jun 15. Clin Infect Dis. 2006. PMID: 16804856 No abstract available.
-
Attributable mortality of Acinetobacter baumannii infection among critically ill patients.Clin Infect Dis. 2006 Aug 1;43(3):389; author reply 389-90. doi: 10.1086/505599. Clin Infect Dis. 2006. PMID: 16804863 No abstract available.
-
Colonization or infection with multidrug-resistant Acinetobacter baumannii may be an independent risk factor for increased mortality.Clin Infect Dis. 2006 Nov 1;43(9):1224-5. doi: 10.1086/508360. Clin Infect Dis. 2006. PMID: 17029151 No abstract available.
Similar articles
-
Risk factors and impact of nosocomial Acinetobacter baumannii bloodstream infections in the adult intensive care unit: a case-control study.J Hosp Infect. 2009 Oct;73(2):143-50. doi: 10.1016/j.jhin.2009.06.007. Epub 2009 Aug 27. J Hosp Infect. 2009. PMID: 19716203
-
Phenotypic and molecular epidemiology of Acinetobacter baumannii strains isolated in Rabta Hospital, Tunisia.Arch Inst Pasteur Tunis. 2007;84(1-4):11-9. Arch Inst Pasteur Tunis. 2007. PMID: 19388579
-
Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options.Clin Infect Dis. 2008 Apr 15;46(8):1254-63. doi: 10.1086/529198. Clin Infect Dis. 2008. PMID: 18444865 Review.
-
Genotypic analysis of Acinetobacter bloodstream infection isolates in a Turkish university hospital.Scand J Infect Dis. 2006;38(5):335-40. doi: 10.1080/00365540500488907. Scand J Infect Dis. 2006. PMID: 16709534
-
Acinetobacter baumannii: an emerging multidrug-resistant threat.Expert Rev Anti Infect Ther. 2008 Jun;6(3):309-25. doi: 10.1586/14787210.6.3.309. Expert Rev Anti Infect Ther. 2008. PMID: 18588496 Review.
Cited by
-
Development and Validation of a Model for Predicting the Risk of Death in Patients with Acinetobacter baumannii Infection: A Retrospective Study.Infect Drug Resist. 2020 Aug 10;13:2761-2772. doi: 10.2147/IDR.S253143. eCollection 2020. Infect Drug Resist. 2020. PMID: 32848426 Free PMC article.
-
A case of fulminant community-acquired Acinetobacter baumannii pneumonia in Korea.Korean J Intern Med. 2013 Jul;28(4):486-90. doi: 10.3904/kjim.2013.28.4.486. Epub 2013 Jul 1. Korean J Intern Med. 2013. PMID: 23864808 Free PMC article.
-
Fungal serotype-specific differences in bacterial-yeast interactions.Virulence. 2015;6(6):652-7. doi: 10.1080/21505594.2015.1066962. Virulence. 2015. PMID: 26132337 Free PMC article.
-
Diversity of Acinetobacter baumannii in four French military hospitals, as assessed by multiple locus variable number of tandem repeats analysis.PLoS One. 2012;7(9):e44597. doi: 10.1371/journal.pone.0044597. Epub 2012 Sep 12. PLoS One. 2012. PMID: 22984530 Free PMC article.
-
In-silico modeling of a novel OXA-51 from β-lactam-resistant Acinetobacter baumannii and its interaction with various antibiotics.J Mol Model. 2012 Jul;18(7):3351-61. doi: 10.1007/s00894-011-1346-3. Epub 2012 Jan 22. J Mol Model. 2012. PMID: 22271096
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical